From Medscape Oncology

Medscape Medical News from the

European Society for Radiotherapy and Oncology (ESTRO) 33

April 04 - 08, 2014; Vienna, Austria

This coverage is not sanctioned by, nor a part of, the European Society for Radiotherapy and Oncology.

Conference News

ESTRO Head & Neck Cancer HPV Status - No Impact Beyond Oropharynx
Medscape Medical News, April 14, 2014
ESTRO Adding ADT to RT Also Best in Milder Prostate Cancer?
Medscape Medical News, April 14, 2014
ESTRO EGFR Inhibition Adds Toxicity, No Benefit in Head, Neck Cancer
Medscape Medical News, April 14, 2014
ESTRO Extra RT Boost in Breast Cancer Has Benefits, Not on Survival
Medscape Medical News, April 14, 2014
ESTRO Lung Cancer: A Dose-Dependent Risk After Breast Cancer RT
Medscape Medical News, April 14, 2014

ESTRO Two Studies: Internal Mammary RT Ups Breast Cancer Survival
Medscape Medical News, April 9, 2014
ESTRO Potency After Prostate Brachytherapy Hinges on Many Factors
Medscape Medical News, April 7, 2014
ESTRO Post-Op Chemo No Help in Adequately Pretreated Rectal Cancer
Medscape Medical News, April 7, 2014
ESTRO Again, Oxaliplatin Is Toxic and No Benefit in Rectal Cancer
Medscape Medical News, April 7, 2014
ESTRO Genomic Signature Predicts Prostate Cancer Metastasis Risk
Medscape Medical News, April 7, 2014

Medscape Oncology© WebMD, LLC

Previous Coverage